Atlas Trials

Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)

Clinical trial NCT03548051 · TERMINATED

Trial details

NCT number
NCT03548051
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clostridial InfectionDysbiosisProbiotic Therapy
Start date
2019-01-11
Primary completion
2021-01-13
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.